Niba, Peter Thelma Ngwa
Nji, Akindeh Mbuh
Ali, Innocent Mbulli
Akam, Lawrence Fonyonga
Dongmo, Cedric Hermann
Chedjou, Jean Paul Kengne
Fomboh, Calvino Tah
Nana, William Dorian
Oben, Ornella Laetitia Ayem
Selly-Ngaloumo, Abdel Aziz
Moyeh, Marcel N.
Ngu, Jude Achidi
Ludovic, Ambassa Jean
Aboh, Pierre Martiniel
Ambani, Marie Carine Enyegue
Omgba, Pierrette Albertine Mbarga
Kotcholi, Grâce Bissohong
Adzemye, Linus Moye
Nna, Danielle Regine Abenkou
Douanla, Adèle
Ango, Ze
Ewane, Marie Sophie
Ticha, Joel Tewara
Tatah, Fritz Mbuh
Dinza, Golwa
Ndikum, Valentine Nchafor
Fosah, Dorothy A.
Bigoga, Jude D.
Alifrangis, Michael
Mbacham, Wilfred F.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Effectiveness and safety of artesunate–amodiaquine versus artemether–lumefantrine for home-based treatment of uncomplicated Plasmodium falciparum malaria among children 6–120 months in Yaoundé, Cameroon: a randomized trial
https://doi.org/10.1186/s12879-022-07101-2
Funding for this research was provided by:
AAS/AESA/Wellcome trust UK (grant # DEL-15-010, grant # DEL-15-010, grant # DEL-15-010, grant # DEL-15-010, grant # DEL-15-010)
Article History
Received: 13 May 2021
Accepted: 29 January 2022
First Online: 21 February 2022
Declarations
:
: This study was reviewed and approved by the Center Regional Ethics Committee (CE Nº 05859/CRERSHC/2019) and National Ethics Committee (Nº 2018/07/1091/CE/CNERSH/SP) for Human Health Research, Ministry of Public Health, Yaoundé, Cameroon. Administrative authorizations were also sought from the Director of District Hospital Cité Verte, Director of District Medical Center Minkoa<b>-</b>Meyos, Center Regional Delegate of Public Health and the Minister of Public Health. In addition, the study was explained using the participant information sheet (PIS) and written assent in French or English was duly obtained from the parents/guardians of each participant before enrolment and collection of samples.
: Not applicable.
: The authors declare that they have no competing interests.